348 related articles for article (PubMed ID: 34015477)
1. Cardiovascular and Kidney Outcomes Across the Glycemic Spectrum: Insights From the UK Biobank.
Honigberg MC; Zekavat SM; Pirruccello JP; Natarajan P; Vaduganathan M
J Am Coll Cardiol; 2021 Aug; 78(5):453-464. PubMed ID: 34015477
[TBL] [Abstract][Full Text] [Related]
2. Associations Between Frailty and the Increased Risk of Adverse Outcomes Among 38,950 UK Biobank Participants With Prediabetes: Prospective Cohort Study.
Cao X; Li X; Zhang J; Sun X; Yang G; Zhao Y; Li S; Hoogendijk EO; Wang X; Zhu Y; Allore H; Gill TM; Liu Z
JMIR Public Health Surveill; 2023 May; 9():e45502. PubMed ID: 37200070
[TBL] [Abstract][Full Text] [Related]
3. Association of Prediabetes With CKD Progression and Adverse Cardiovascular Outcomes: An Analysis of the CRIC Study.
Neves JS; Correa S; Baeta Baptista R; Bigotte Vieira M; Waikar SS; Mc Causland FR
J Clin Endocrinol Metab; 2020 Apr; 105(4):e1772-80. PubMed ID: 31943096
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular and renal burdens of prediabetes in the USA: analysis of data from serial cross-sectional surveys, 1988-2014.
Ali MK; Bullard KM; Saydah S; Imperatore G; Gregg EW
Lancet Diabetes Endocrinol; 2018 May; 6(5):392-403. PubMed ID: 29500121
[TBL] [Abstract][Full Text] [Related]
5. Glycated Hemoglobin, Prediabetes, and the Links to Cardiovascular Disease: Data From UK Biobank.
Welsh C; Welsh P; Celis-Morales CA; Mark PB; Mackay D; Ghouri N; Ho FK; Ferguson LD; Brown R; Lewsey J; Cleland JG; Gray SR; Lyall DM; Anderson JJ; Jhund PS; Pell JP; McGuire DK; Gill JMR; Sattar N
Diabetes Care; 2020 Feb; 43(2):440-445. PubMed ID: 31852727
[TBL] [Abstract][Full Text] [Related]
6. Association of prediabetes with clinical outcomes in patients with chronic coronary syndrome: a post hoc analysis of the ISCHEMIA and ISCHEMIA-CKD trials.
Jorda A; Hengstenberg C; Lang IM; Kautzky-Willer A; Harreiter J; Zeitlinger M; Jilma B; Gelbenegger G
Cardiovasc Diabetol; 2024 May; 23(1):176. PubMed ID: 38769562
[TBL] [Abstract][Full Text] [Related]
7. Lipoprotein(a) levels and risk of cardiovascular disease events in individuals with diabetes mellitus or prediabetes: The Atherosclerosis Risk in Communities study.
Saeed A; Sun W; Agarwala A; Virani SS; Nambi V; Coresh J; Selvin E; Boerwinkle E; Jones PH; Ballantyne CM; Hoogeveen RC
Atherosclerosis; 2019 Mar; 282():52-56. PubMed ID: 30685442
[TBL] [Abstract][Full Text] [Related]
8. Associations of New-Onset Atrial Fibrillation With Risks of Cardiovascular Disease, Chronic Kidney Disease, and Mortality Among Patients With Type 2 Diabetes.
Geng T; Wang Y; Lu Q; Zhang YB; Chen JX; Zhou YF; Wan Z; Guo K; Yang K; Liu L; Liu G; Pan A
Diabetes Care; 2022 Oct; 45(10):2422-2429. PubMed ID: 35984477
[TBL] [Abstract][Full Text] [Related]
9. Ideal Cardiovascular Health Metrics and Major Cardiovascular Events in Patients With Prediabetes and Diabetes.
Wang T; Lu J; Su Q; Chen Y; Bi Y; Mu Y; Chen L; Hu R; Tang X; Yu X; Li M; Xu M; Xu Y; Zhao Z; Yan L; Qin G; Wan Q; Chen G; Dai M; Zhang D; Gao Z; Wang G; Shen F; Luo Z; Qin Y; Chen L; Huo Y; Li Q; Ye Z; Zhang Y; Liu C; Wang Y; Wu S; Yang T; Deng H; Li D; Lai S; Bloomgarden ZT; Shi L; Ning G; Zhao J; Wang W;
JAMA Cardiol; 2019 Sep; 4(9):874-883. PubMed ID: 31365039
[TBL] [Abstract][Full Text] [Related]
10. Atherosclerotic Cardiovascular Disease or Heart Failure: First Cardiovascular Event in Adults With Prediabetes and Diabetes.
Sinha A; Ning H; Cameron N; Bancks M; Carnethon MR; Allen NB; Wilkins JT; Lloyd-Jones DM; Khan SS
J Card Fail; 2023 Mar; 29(3):246-254. PubMed ID: 36343785
[TBL] [Abstract][Full Text] [Related]
11. Cardiometabolic Risk Profiles in Patients With Impaired Fasting Glucose and/or Hemoglobin A1c 5.7% to 6.4%: Evidence for a Gradient According to Diagnostic Criteria: The PREDAPS Study.
Giráldez-García C; Sangrós FJ; Díaz-Redondo A; Franch-Nadal J; Serrano R; Díez J; Buil-Cosiales P; García-Soidán FJ; Artola S; Ezkurra P; Carrillo L; Millaruelo JM; Seguí M; Martínez-Candela J; Muñoz P; Goday A; Regidor E;
Medicine (Baltimore); 2015 Nov; 94(44):e1935. PubMed ID: 26554799
[TBL] [Abstract][Full Text] [Related]
12. Glycated hemoglobin variability and the risk of cardiovascular events in patients with prediabetes and type 2 diabetes mellitus: A post-hoc analysis of a prospective and multicenter study.
Manosroi W; Phimphilai M; Waisayanand N; Buranapin S; Deerochanawong C; Gunaparn S; Phrommintikul A; Wongcharoen W;
J Diabetes Investig; 2023 Dec; 14(12):1391-1400. PubMed ID: 37610280
[TBL] [Abstract][Full Text] [Related]
13. Prediabetes increases the risk of major limb and cardiovascular events.
Hsu JC; Yang YY; Chuang SL; Lee JK; Lin LY
Cardiovasc Diabetol; 2023 Dec; 22(1):348. PubMed ID: 38115080
[TBL] [Abstract][Full Text] [Related]
14. Association of Serum 25-Hydroxyvitamin D With Cardiovascular Outcomes and All-Cause Mortality in Individuals With Prediabetes and Diabetes: Results From the UK Biobank Prospective Cohort Study.
Zhang P; Guo D; Xu B; Huang C; Yang S; Wang W; Liu W; Deng Y; Li K; Liu D; Lin J; Wei X; Huang Y; Zhang H
Diabetes Care; 2022 May; 45(5):1219-1229. PubMed ID: 35226734
[TBL] [Abstract][Full Text] [Related]
15. Glycemic status and its association with retinal age gap: Insights from the UK biobank study.
Chen R; Xu J; Zhang X; Zhang J; Shang X; Ge Z; He M; Wang W; Zhu Z
Diabetes Res Clin Pract; 2023 Aug; 202():110817. PubMed ID: 37419389
[TBL] [Abstract][Full Text] [Related]
16. Exploring the Underlying Mechanisms Linking Adiposity and Cardiovascular Disease: A Prospective Cohort Study of 404,332 UK Biobank Participants.
Zhou Z; Parra-Soto S; Boonpor J; Petermann-Rocha F; Welsh P; Mark PB; Sattar N; Pell JP; Celis-Morales C; Ho FK
Curr Probl Cardiol; 2023 Aug; 48(8):101715. PubMed ID: 37004891
[TBL] [Abstract][Full Text] [Related]
17. The impact of major depressive disorder on glycaemic control in type 2 diabetes: a longitudinal cohort study using UK Biobank primary care records.
Gillett AC; Hagenaars SP; Handley D; Casanova F; Young KG; Green H; Lewis CM; Tyrrell J
BMC Med; 2024 May; 22(1):211. PubMed ID: 38807170
[TBL] [Abstract][Full Text] [Related]
18. Glycated Hemoglobin as an Integrator of Cardiovascular Risk in Individuals Without Diabetes: Lessons from Recent Epidemiologic Studies.
Hoffmann AP; Honigberg MC
Curr Atheroscler Rep; 2022 Jun; 24(6):435-442. PubMed ID: 35386092
[TBL] [Abstract][Full Text] [Related]
19. Regression from prediabetes to normal glucose regulation is associated with reduction in cardiovascular risk: results from the Diabetes Prevention Program outcomes study.
Perreault L; Temprosa M; Mather KJ; Horton E; Kitabchi A; Larkin M; Montez MG; Thayer D; Orchard TJ; Hamman RF; Goldberg RB;
Diabetes Care; 2014 Sep; 37(9):2622-31. PubMed ID: 24969574
[TBL] [Abstract][Full Text] [Related]
20. Multimorbidity, mortality, and HbA1c in type 2 diabetes: A cohort study with UK and Taiwanese cohorts.
Chiang JI; Hanlon P; Li TC; Jani BD; Manski-Nankervis JA; Furler J; Lin CC; Yang SY; Nicholl BI; Thuraisingam S; Mair FS
PLoS Med; 2020 May; 17(5):e1003094. PubMed ID: 32379755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
